Skip to content
Clinical Trials – home
Region Skane
Sponsor

Region Skane

Sweden Dockplatsen 26, Malmo S:t Petri, 211 74 Malmo, Sweden

About the sponsor

Research activity includes treatment strategies for non-small cell lung cancer, triple-negative breast cancer, dedifferentiated liposarcoma, mantle cell lymphoma, diffuse large B-cell lymphoma, gastrointestinal stromal tumor, and neuroendocrine tumours. Additional interest is seen in papillary craniopharyngioma and resectable gastric and gastroesophageal junction adenocarcinoma.

  • Solid tumours
  • Lymphoma
  • Targeted cancer therapy
  • Perioperative oncology

Its oncology portfolio spans both tumour-directed therapy and disease-specific management across adult and selected rare cancers.

About Specializations

Region Skane runs clinical trials in conditions such as Endocrine ophthalmopathy, Bipolar disorder, Major depression, Mantle cell lymphoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

34 clinical trials

Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Flutemetamol (18F)
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Adenosine
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Afatinib
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Simvastatin
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3',4'-D]Pyrrole
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cloxacillin
  • Sponsor:Region Skane
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pemigatinib
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin
  • Sponsor:Region Skane
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dabrafenib
  • Sponsor:Region Skane

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.